TELA Bio, Inc. filed 3 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-08-31. Between them they name 2 people, with 1 appointment and 1 departure. Each change below is quoted from the filing and linked to it.
Every change, newest first
Reported
Effective on August 31, 2026, Roberto Cuca stepped down from his position as the Company's Chief Financial Officer, Chief Operating Officer, Corporate Secretary and principal financial officer.
Departing: Antony Koblish, Director
In addition, on August 3, 2026, Mr. Koblish, a member of the Board, tendered his resignation from the Board, effective as of 12:01 am ET on the Effective Date.
Appointed: Guido Neels, Director
On April 29, 2026, in connection with the Resigning Directors' resignations, the Board appointed Guido Neels as a Class II director, with a term expiring at the 2027 Annual Meeting of the Company, and Guy Nohra and Paul Thomas as Class III directors, with terms expiring at the 2028 Annual Meeting of the Company (together, the " Incoming Directors "), in each case effective immediately following the 2026 Annual Meeting.
Find people with the same kind of experience as the Director at TELA Bio, Inc., with the record behind each one.
Find candidates like Director at TELA Bio, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time TELA Bio, Inc. is in the news or changes leadership.
Get an alert when TELA Bio, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for TELA Bio, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.